Search
Drug companies threaten legal fight over cheaper drug
Latest news, posted 1 November 2017
Health chiefs face a legal fight over plans to give a cheap drug to patients with wet age-related macular degeneration (AMD).
Eylea approved for myopic CNV patients
Latest news, posted 1 November 2017
The National Institute of Health and Care Excellence (NICE) has recommended the use of Eylea® on adults for treating visual impairment due to myopic chorodial neovascularisation (CNV).Pathological myopia, also known as severe near sightedness, affects 3%…
Do you want a place in the London Marathon?
Latest news, posted 8 November 2017
Have you always wanted to run the London Marathon but struggled to get a place?Now could be your chance to do just that, while raising vital funds for people with macular disease.The Macular Society has a coveted place in next year’s race and is calling …
FDA investigate potential Stargardt treatment
Latest news, posted 13 November 2017
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a drug to help treat Stargardt disease, according to Lin BioScience.The drug, known as LBS-008, is designed to prevent the build-up of a toxin in the eye called lipofuscin…
Coming up in winter’s Sideview
Latest news, posted 14 November 2017
The latest issue of Sideview magazine will be sent out to 22,000 Macular Society members in late November.
Charles Bonnet Awareness Day
Latest news, posted 14 November 2017
As part of our Charles Bonnet campaign, which launched last month, we encouraged people to talk openly about their hallucinations.Today, to mark Charles Bonnet Awareness Day
Petition reaches more than 11,000 signatures
Latest news, posted 20 November 2017
More than 11,000 people signed our petition to end needless sight loss, after a Macular Society volunteer was forced to invade the headquarters of his local healthcare commissioners when he experienced delays to treatment.Chris Thorley waited more than n…
New drug could mean less frequent injections
Latest news, posted 21 November 2017
Results from a recent clinical trial suggest that a possible new treatment for wet age-related macular degeneration (AMD) could control symptoms as effectively as current treatments, with less frequent injections.The late-stage trials have revealed the d…
Images used to educate public about AMD not realistic, says study
Latest news, posted 27 November 2017
Images used to educate the public about vision loss due to the leading causes of blindness are not fit for purpose, according to a new study from City, University of London.The researchers found that the image commonly used to represent age-related macul…
Research priorities agreed to stop early age-related macular degeneration (AMD) turning into late AMD at Wellcome retreat
Latest news, posted 28 November 2017
Three leading sight loss charities, Blind Veterans UK, Fight for Sight and the Macular Society, have joined forces in the global fight against age-related macular degeneration (AMD).